Skip to content

Calcium for Prevention of Ovarian Hyperstimulation Syndrome

Does Intravenous Calcium Infusion Effectively Prevent OHSS : a Randomised Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01427335
Acronym
OHSS
Enrollment
200
Registered
2011-09-01
Start date
2011-10-31
Completion date
2013-09-30
Last updated
2014-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Hyperstimulation Syndrome

Keywords

OHSS, ICSI, calcium injection

Brief summary

There are many protocols for prevention of ovarian hyperstimulation syndrome, intravenous calcium is a novel protocol. But still there is lack of evidence of it is real effect in prevention of OHSS & the mechanism of its action is still questionable . In the study the investigators try to search for the evidence for its effect & the real mechanism for its action.

Detailed description

The study population will be divided into 2groups each containing 100 infertile couples candidate for ICSI. Group (A)active group: administration of 10% Intravenous calcium gluconate 10 ml in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes. Group (B): placebo group: administration of 200 mL of 0.9% saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup. Intravenous infusion was performed within 30 minutes

Interventions

DRUGcalcium

intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group. Intravenous infusion was performed within 30 minutes

0.9 % saline intravenous infusion

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* infertile women aged 20 to 38 years. * BMI ranged from 18 to 40. * serum FSH within normal limits( 1-12IU /l) * presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.

Exclusion criteria

* endocrinopathies. * a systemic disease. * using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists. * patients need coasting for high risk of OHSS. * patients need cycle cancellation. * severe male infertility requiring testicular sperm extraction.

Design outcomes

Primary

MeasureTime frameDescription
OHSS rate2 yearsovarain hyperstimulation syndrome

Secondary

MeasureTime frameDescription
clinical pregnancy rate2 yearspositive pregnancy test and positive fetal heart beat after 6 weeks gestaional age

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026